{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:22:37Z","timestamp":1793388157731,"version":"4.5.0"},"reference-count":109,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Medical Research Project of Yancheng Health Commission","award":["No.YK2023130"],"award-info":[{"award-number":["No.YK2023130"]}]},{"name":"The Special Scientific Research Fund for Clinical Medicine of Nantong University","award":["No.2024LZ006"],"award-info":[{"award-number":["No.2024LZ006"]}],"id":[{"id":"https:\/\/ror.org\/02afcvw97","id-type":"ROR","asserted-by":"crossref"}]},{"name":"The Special Scientific Research Fund for Clinical Medicine of Nantong University","award":["2024LZ008"],"award-info":[{"award-number":["2024LZ008"]}],"id":[{"id":"https:\/\/ror.org\/02afcvw97","id-type":"ROR","asserted-by":"crossref"}]},{"name":"The Special Fund Project of Yancheng Science and Technology Bureau","award":["No.YCBE202475"],"award-info":[{"award-number":["No.YCBE202475"]}],"id":[{"id":"https:\/\/ror.org\/044zx0n67","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-03264-1","type":"journal-article","created":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T15:50:38Z","timestamp":1760457038000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Gut microbiota and metabolism in systemic lupus erythematosus: from dysbiosis to targeted interventions"],"prefix":"10.1186","volume":"30","author":[{"given":"Jing-he","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-pei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Gang","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-bin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-xiu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,14]]},"reference":[{"issue":"17","key":"3264_CR1","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1001\/jama.2024.2315","volume":"331","author":"CH Siegel","year":"2024","unstructured":"Siegel CH, Sammaritano LR. Systemic lupus erythematosus: a review [published correction appears in JAMA. 2024 Jun 25;331(24):2136.]. JAMA. 2024;331(17):1480\u201391.","journal-title":"JAMA"},{"issue":"7","key":"3264_CR2","first-page":"775","volume":"62","author":"N Shen","year":"2023","unstructured":"Shen N, Zhao Y, Duan LH, et al. Recommendations for diagnosis and treatment of systemic lupus erythematosus. Chin J Intern Med. 2023;62(7):775\u201384.","journal-title":"Chin J Intern Med"},{"issue":"1","key":"3264_CR3","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41392-025-02168-0","volume":"10","author":"X Dai","year":"2025","unstructured":"Dai X, Fan Y, Zhao X. Systemic lupus erythematosus: updated insights on the pathogenesis, diagnosis, prevention and therapeutics. Signal Transduct Target Ther. 2025;10(1):102.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"3264_CR4","doi-asserted-by":"publisher","first-page":"e005050","DOI":"10.1136\/rmdopen-2024-005050","volume":"11","author":"P Garantziotis","year":"2025","unstructured":"Garantziotis P, Moysidou GS, Kapsala N, et al. Transcriptome analysis to decipher the molecular underpinnings of response to treatment in systemic lupus erythematosus. RMD Open. 2025;11(1):e005050.","journal-title":"RMD Open"},{"issue":"2","key":"3264_CR5","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/s41579-023-00969-0","volume":"22","author":"G McCallum","year":"2024","unstructured":"McCallum G, Tropini C. The gut microbiota and its biogeography. Nat Rev Microbiol. 2024;22(2):105\u201318.","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"3264_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41577-022-00727-y","volume":"23","author":"E Miyauchi","year":"2023","unstructured":"Miyauchi E, Shimokawa C, Steimle A, Desai MS, Ohno H. The impact of the gut microbiome on extra-intestinal autoimmune diseases. Nat Rev Immunol. 2023;23(1):9\u201323.","journal-title":"Nat Rev Immunol"},{"key":"3264_CR7","doi-asserted-by":"publisher","first-page":"799788","DOI":"10.3389\/fimmu.2021.799788","volume":"12","author":"Q Pan","year":"2021","unstructured":"Pan Q, Guo F, Huang Y, et al. Gut microbiota dysbiosis in Systemic Lupus Erythematosus: novel insights into mechanisms and promising therapeutic strategies. Front Immunol. 2021;12:799788.","journal-title":"Front Immunol"},{"issue":"12","key":"3264_CR8","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s11926-023-01115-8","volume":"25","author":"FNC Kalayci","year":"2023","unstructured":"Kalayci FNC, Ozen S. Possible role of dysbiosis of the gut microbiome in SLE. Curr Rheumatol Rep. 2023;25(12):247\u201358.","journal-title":"Curr Rheumatol Rep"},{"issue":"2","key":"3264_CR9","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41579-020-0438-4","volume":"19","author":"KA Krautkramer","year":"2021","unstructured":"Krautkramer KA, Fan J, B\u00e4ckhed F. Gut microbial metabolites as multi-kingdom intermediates. Nat Rev Microbiol. 2021;19(2):77\u201394.","journal-title":"Nat Rev Microbiol"},{"key":"3264_CR10","doi-asserted-by":"publisher","first-page":"686501","DOI":"10.3389\/fimmu.2021.686501","volume":"12","author":"L Zhang","year":"2021","unstructured":"Zhang L, Qing P, Yang H, Wu Y, Liu Y, Luo Y. Gut microbiome and metabolites in systemic lupus erythematosus: link, mechanisms and intervention. Front Immunol. 2021;12:686501.","journal-title":"Front Immunol"},{"issue":"11","key":"3264_CR11","doi-asserted-by":"publisher","first-page":"5608","DOI":"10.3390\/ijms25115608","volume":"25","author":"AM Vitale","year":"2024","unstructured":"Vitale AM, Paladino L, Caruso Bavisotto C, et al. Interplay between the chaperone system and gut microbiota dysbiosis in systemic lupus erythematosus pathogenesis: is molecular mimicry the missing link between those two factors? Int J Mol Sci. 2024;25(11):5608.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3264_CR12","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13099-025-00683-7","volume":"17","author":"AY Ali","year":"2025","unstructured":"Ali AY, Zahran SA, Eissa M, Kashef MT, Ali AE. Gut microbiota dysbiosis and associated immune response in systemic lupus erythematosus: impact of disease and treatment. Gut Pathog. 2025;17(1):10.","journal-title":"Gut Pathog"},{"key":"3264_CR13","doi-asserted-by":"publisher","first-page":"943241","DOI":"10.3389\/fimmu.2022.943241","volume":"13","author":"E Toumi","year":"2022","unstructured":"Toumi E, Goutorbe B, Plauzolles A, et al. Gut microbiota in systemic lupus erythematosus patients and lupus mouse model: a cross species comparative analysis for biomarker discovery. Front Immunol. 2022;13:943241.","journal-title":"Front Immunol"},{"issue":"6","key":"3264_CR14","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1080\/19490976.2020.1768644","volume":"11","author":"M Guo","year":"2020","unstructured":"Guo M, Wang H, Xu S, et al. Alteration in gut microbiota is associated with dysregulation of cytokines and glucocorticoid therapy in systemic lupus erythematosus. Gut Microbes. 2020;11(6):1758\u201373.","journal-title":"Gut Microbes"},{"issue":"6","key":"3264_CR15","doi-asserted-by":"publisher","first-page":"592","DOI":"10.3899\/jrheum.210952","volume":"49","author":"WA James","year":"2022","unstructured":"James WA, Ogunrinde E, Wan Z, et al. A distinct plasma microbiome but not gut microbiome in patients with systemic lupus erythematosus compared to healthy individuals. J Rheumatol. 2022;49(6):592\u20137.","journal-title":"J Rheumatol"},{"key":"3264_CR16","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.molimm.2024.05.004","volume":"171","author":"S Quesada","year":"2024","unstructured":"Quesada S, Rosso AD, Mascardi F, et al. Integrative analysis of systemic lupus erythematosus biomarkers: role of fecal hsa-mir-223-3p and gut microbiota in transkingdom dynamics. Mol Immunol. 2024;171:77\u201392.","journal-title":"Mol Immunol"},{"key":"3264_CR17","doi-asserted-by":"publisher","first-page":"915179","DOI":"10.3389\/fmed.2022.915179","volume":"9","author":"X Wang","year":"2022","unstructured":"Wang X, Shu Q, Song L, Liu Q, Qu X, Li M. Gut microbiota in systemic lupus erythematosus and correlation with diet and clinical manifestations. Front Med (Lausanne). 2022;9:915179.","journal-title":"Front Med (Lausanne)"},{"issue":"12","key":"3264_CR18","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1136\/annrheumdis-2021-220687","volume":"80","author":"Y Tomofuji","year":"2021","unstructured":"Tomofuji Y, Maeda Y, Oguro-Igashira E, et al. Metagenome-wide association study revealed disease-specific landscape of the gut microbiome of systemic lupus erythematosus in Japanese. Ann Rheum Dis. 2021;80(12):1575\u201383.","journal-title":"Ann Rheum Dis"},{"key":"3264_CR19","doi-asserted-by":"publisher","first-page":"1135861","DOI":"10.3389\/fimmu.2023.1135861","volume":"14","author":"Z Ling","year":"2023","unstructured":"Ling Z, Cheng Y, Gao J, et al. Alterations of the fecal and vaginal microbiomes in patients with systemic lupus erythematosus and their associations with immunological profiles. Front Immunol. 2023;14:1135861.","journal-title":"Front Immunol"},{"key":"3264_CR20","doi-asserted-by":"publisher","first-page":"626217","DOI":"10.3389\/fimmu.2021.626217","volume":"12","author":"F Liu","year":"2021","unstructured":"Liu F, Ren T, Li X, et al. Distinct microbiomes of gut and saliva in patients with systemic lupus erythematosus and clinical associations. Front Immunol. 2021;12:626217.","journal-title":"Front Immunol"},{"issue":"1","key":"3264_CR21","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1136\/ard-2024-225829","volume":"84","author":"H Zhou","year":"2025","unstructured":"Zhou H, Balint D, Shi Q, Vartanian T, Kriegel MA, Brito I. Lupus and inflammatory bowel disease share a common set of microbiome features distinct from other autoimmune disorders. Ann Rheum Dis. 2025;84(1):93\u2013105.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"3264_CR22","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/art.41511","volume":"73","author":"BD Chen","year":"2021","unstructured":"Chen BD, Jia XM, Xu JY, et al. An autoimmunogenic and proinflammatory profile defined by the gut microbiota of patients with untreated systemic lupus erythematosus. Arthritis Rheumatol. 2021;73(2):232\u201343.","journal-title":"Arthritis Rheumatol"},{"key":"3264_CR23","doi-asserted-by":"publisher","first-page":"5579608","DOI":"10.1155\/2021\/5579608","volume":"2021","author":"M Wen","year":"2021","unstructured":"Wen M, Liu T, Zhao M, et al. Correlation analysis between gut microbiota and metabolites in children with Systemic Lupus Erythematosus. J Immunol Res. 2021;2021:5579608.","journal-title":"J Immunol Res"},{"issue":"7","key":"3264_CR24","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1136\/annrheumdis-2018-214856","volume":"78","author":"D Azzouz","year":"2019","unstructured":"Azzouz D, Omarbekova A, Heguy A, et al. Lupus nephritis is linked to disease-activity associated expansions and immunity to a gut commensal. Ann Rheum Dis. 2019;78(7):947\u201356.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"3264_CR25","doi-asserted-by":"publisher","first-page":"32076","DOI":"10.1038\/s41598-024-83835-0","volume":"14","author":"J Nishio","year":"2024","unstructured":"Nishio J, Sato H, Watanabe E, et al. Associations of gut microbiota with disease development, disease activity, and therapeutic effects in patients with systemic lupus erythematosus. Sci Rep. 2024;14(1):32076.","journal-title":"Sci Rep"},{"issue":"1","key":"3264_CR26","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s13075-024-03413-7","volume":"26","author":"L Gui","year":"2024","unstructured":"Gui L, Zuo X, Feng J, et al. Outgrowth of Escherichia is susceptible to aggravation of systemic lupus erythematosus. Arthritis Res Ther. 2024;26(1):191.","journal-title":"Arthritis Res Ther"},{"key":"3264_CR27","doi-asserted-by":"publisher","first-page":"667097","DOI":"10.3389\/fimmu.2021.667097","volume":"12","author":"K Xiang","year":"2021","unstructured":"Xiang K, Wang P, Xu Z, et al. Causal effects of gut microbiome on systemic Lupus Erythematosus: a two-sample Mendelian randomization study. Front Immunol. 2021;12:667097.","journal-title":"Front Immunol"},{"issue":"1","key":"3264_CR28","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12865-024-00632-0","volume":"25","author":"FP Lian","year":"2024","unstructured":"Lian FP, Zhang F, Zhao CM, et al. Gut microbiota regulation of T lymphocyte subsets during systemic lupus erythematosus. BMC Immunol. 2024;25(1):41.","journal-title":"BMC Immunol"},{"issue":"8","key":"3264_CR29","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.3390\/nu15081999","volume":"15","author":"BD Balmant","year":"2023","unstructured":"Balmant BD, Fonseca DC, Prud\u00eancio APA, et al. Megamonas funiformis, Plasma Zonulin, and Sodium Intake Affect C3 Complement Levels in Inactive Systemic Lupus Erythematosus. Nutrients. 2023;15(8):1999.","journal-title":"Nutrients"},{"issue":"5","key":"3264_CR30","doi-asserted-by":"publisher","first-page":"e0021222","DOI":"10.1128\/spectrum.00212-22","volume":"10","author":"F Liu","year":"2022","unstructured":"Liu F, Du J, Zhai Q, et al. The bladder microbiome, metabolome, cytokines, and phenotypes in patients with systemic lupus erythematosus. Microbiol Spectr. 2022;10(5):e0021222.","journal-title":"Microbiol Spectr"},{"issue":"7","key":"3264_CR31","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1042\/CS20180841","volume":"133","author":"Y Li","year":"2019","unstructured":"Li Y, Wang HF, Li X, et al. Disordered intestinal microbes are associated with the activity of Systemic Lupus Erythematosus. Clin Sci (Lond). 2019;133(7):821\u201338.","journal-title":"Clin Sci (Lond)"},{"issue":"6","key":"3264_CR32","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1007\/s10067-025-07435-7","volume":"44","author":"RL Lu","year":"2025","unstructured":"Lu RL, Chen YR, Yang XF, Huang XY, Liu DZ, Hong XP. Genetic liability to gut microbiota and inflammatory cytokines in relation to systemic lupus erythematosus risk: a multi-omics study. Clin Rheumatol. 2025;44(6):2257\u201368.","journal-title":"Clin Rheumatol"},{"issue":"10","key":"3264_CR33","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1136\/ard-2023-223929","volume":"82","author":"DF Azzouz","year":"2023","unstructured":"Azzouz DF, Chen Z, Izmirly PM, et al. Longitudinal gut microbiome analyses and blooms of pathogenic strains during lupus disease flares. Ann Rheum Dis. 2023;82(10):1315\u201327.","journal-title":"Ann Rheum Dis"},{"key":"3264_CR34","doi-asserted-by":"publisher","first-page":"1471177","DOI":"10.3389\/fmicb.2024.1471177","volume":"15","author":"L Chero-Sandoval","year":"2024","unstructured":"Chero-Sandoval L, Higuera-G\u00f3mez A, Cuevas-Sierra A, et al. Body mass index and fat influences the role of Bifidobacterium genus in lupus patients concerning fibrinogen levels. Front Microbiol. 2024;15:1471177.","journal-title":"Front Microbiol"},{"key":"3264_CR35","doi-asserted-by":"publisher","first-page":"897971","DOI":"10.3389\/fimmu.2022.897971","volume":"13","author":"GJ Silverman","year":"2022","unstructured":"Silverman GJ, Deng J, Azzouz DF. Sex-dependent Lupus Blautia (Ruminococcus) gnavus strain induction of zonulin-mediated intestinal permeability and autoimmunity. Front Immunol. 2022;13:897971.","journal-title":"Front Immunol"},{"issue":"2","key":"3264_CR36","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/imm.13713","volume":"171","author":"RR Gudi","year":"2024","unstructured":"Gudi RR, Johnson BM, Gaudreau MC, Sun W, Ball L, Vasu C. Intestinal permeability and inflammatory features of juvenile age correlate with the eventual systemic autoimmunity in lupus-prone female SWR \u00d7 NZB F1 (SNF1) mice. Immunology. 2024;171(2):235\u201349.","journal-title":"Immunology"},{"key":"3264_CR37","doi-asserted-by":"publisher","first-page":"651191","DOI":"10.3389\/fimmu.2021.651191","volume":"12","author":"H Wang","year":"2021","unstructured":"Wang H, Wang G, Banerjee N, et al. Aberrant gut microbiome contributes to intestinal oxidative stress, barrier dysfunction, inflammation and systemic autoimmune responses in MRL\/lpr mice. Front Immunol. 2021;12:651191.","journal-title":"Front Immunol"},{"issue":"4","key":"3264_CR38","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1002\/art.42016","volume":"74","author":"M Shirakashi","year":"2022","unstructured":"Shirakashi M, Maruya M, Hirota K, et al. Effect of impaired T cell receptor signaling on the gut microbiota in a mouse model of systemic autoimmunity. Arthritis Rheumatol. 2022;74(4):641\u201353.","journal-title":"Arthritis Rheumatol"},{"key":"3264_CR39","doi-asserted-by":"publisher","first-page":"696810","DOI":"10.3389\/fimmu.2021.696810","volume":"12","author":"LA Sch\u00e4fer","year":"2021","unstructured":"Sch\u00e4fer LA, Eichhorst A, Hentze C, et al. Low dietary fiber intake links development of obesity and lupus pathogenesis. Front Immunol. 2021;12:696810.","journal-title":"Front Immunol"},{"key":"3264_CR40","doi-asserted-by":"publisher","first-page":"635072","DOI":"10.3389\/fimmu.2021.635072","volume":"12","author":"H Bagavant","year":"2021","unstructured":"Bagavant H, Araszkiewicz AM, Ingram JK, et al. Immune response to Enterococcus gallinarum in lupus patients is associated with a subset of lupus-associated autoantibodies. Front Immunol. 2021;12:635072.","journal-title":"Front Immunol"},{"issue":"551","key":"3264_CR41","doi-asserted-by":"publisher","first-page":"eaax2220","DOI":"10.1126\/scitranslmed.aax2220","volume":"12","author":"SC Choi","year":"2020","unstructured":"Choi SC, Brown J, Gong M, et al. Gut microbiota dysbiosis and altered tryptophan catabolism contribute to autoimmunity in lupus-susceptible mice. Sci Transl Med. 2020;12(551):eaax2220.","journal-title":"Sci Transl Med"},{"issue":"784","key":"3264_CR42","doi-asserted-by":"publisher","first-page":"eadj6294","DOI":"10.1126\/scitranslmed.adj6294","volume":"17","author":"K Gronke","year":"2025","unstructured":"Gronke K, Nguyen M, Fuhrmann H, et al. Translocating gut pathobiont Enterococcus gallinarum induces TH17 and IgG3 anti-RNA-directed autoimmunity in mouse and human. Sci Transl Med. 2025;17(784):eadj6294.","journal-title":"Sci Transl Med"},{"issue":"3","key":"3264_CR43","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.3390\/ijms26031006","volume":"26","author":"EJ Han","year":"2025","unstructured":"Han EJ, Ahn JS, Choi YJ, Kim DH, Chung HJ. Changes in gut microbiota according to disease severity in a lupus mouse model. Int J Mol Sci. 2025;26(3):1006.","journal-title":"Int J Mol Sci"},{"key":"3264_CR44","doi-asserted-by":"publisher","first-page":"104055","DOI":"10.1016\/j.ebiom.2022.104055","volume":"80","author":"Y Wang","year":"2022","unstructured":"Wang Y, Wei J, Zhang W, et al. Gut dysbiosis in rheumatic diseases: a systematic review and meta-analysis of 92 observational studies. EBioMedicine. 2022;80:104055.","journal-title":"EBioMedicine"},{"issue":"18","key":"3264_CR45","doi-asserted-by":"publisher","first-page":"4318","DOI":"10.1039\/D3AN01051A","volume":"148","author":"Q Du","year":"2023","unstructured":"Du Q, Wang X, Chen J, et al. Machine learning encodes urine and serum metabolic patterns for autoimmune disease discrimination, classification and metabolic dysregulation analysis [published correction appears in Analyst. 2023;148(18):4557.]. Analyst. 2023;148(18):4318\u201330.","journal-title":"Analyst"},{"key":"3264_CR46","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.3389\/fimmu.2020.01703","volume":"11","author":"J He","year":"2020","unstructured":"He J, Chan T, Hong X, et al. Microbiome and metabolome analyses reveal the disruption of lipid metabolism in systemic lupus erythematosus. Front Immunol. 2020;11:1703.","journal-title":"Front Immunol"},{"issue":"4","key":"3264_CR47","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1161\/ATVBAHA.120.315321","volume":"41","author":"L Coelewij","year":"2021","unstructured":"Coelewij L, Waddington KE, Robinson GA, et al. Serum metabolomic signatures can predict subclinical atherosclerosis in patients with systemic lupus erythematosus. Arterioscler Thromb Vasc Biol. 2021;41(4):1446\u201358.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"3264_CR48","doi-asserted-by":"publisher","first-page":"e000254","DOI":"10.1136\/lupus-2017-000254","volume":"5","author":"K \u00c5kesson","year":"2018","unstructured":"\u00c5kesson K, Pettersson S, St\u00e5hl S, et al. Kynurenine pathway is altered in patients with SLE and associated with severe fatigue. Lupus Sci Med. 2018;5(1):e000254.","journal-title":"Lupus Sci Med"},{"issue":"1","key":"3264_CR49","doi-asserted-by":"publisher","first-page":"e000559","DOI":"10.1136\/lupus-2021-000559","volume":"8","author":"EW Anderson","year":"2021","unstructured":"Anderson EW, Fishbein J, Hong J, et al. Quinolinic acid, a kynurenine\/tryptophan pathway metabolite, associates with impaired cognitive test performance in systemic lupus erythematosus. Lupus Sci Med. 2021;8(1):e000559.","journal-title":"Lupus Sci Med"},{"issue":"1","key":"3264_CR50","doi-asserted-by":"publisher","first-page":"e000808","DOI":"10.1136\/lupus-2022-000808","volume":"9","author":"EW Anderson","year":"2022","unstructured":"Anderson EW, Jin Y, Shih A, et al. Associations between circulating interferon and kynurenine\/tryptophan pathway metabolites: support for a novel potential mechanism for cognitive dysfunction in SLE. Lupus Sci Med. 2022;9(1):e000808.","journal-title":"Lupus Sci Med"},{"issue":"12","key":"3264_CR51","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1007\/s00726-023-03353-7","volume":"55","author":"D Eryavuz Onmaz","year":"2023","unstructured":"Eryavuz Onmaz D, Tezcan D, Yilmaz S, Onmaz M, Unlu A. Altered kynurenine pathway metabolism and association with disease activity in patients with systemic lupus. Amino Acids. 2023;55(12):1937\u201347.","journal-title":"Amino Acids"},{"issue":"3","key":"3264_CR52","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/art.42722","volume":"76","author":"J Peng","year":"2024","unstructured":"Peng J, D\u00f6nnes P, Ardoin SP, et al. Atherosclerosis progression in the APPLE trial can be predicted in young people with juvenile-onset systemic lupus erythematosus using a novel lipid metabolomic signature. Arthritis Rheumatol. 2024;76(3):455\u201368.","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"3264_CR53","first-page":"15","volume":"42","author":"KT Tang","year":"2024","unstructured":"Tang KT, Chien HJ, Chang YH, Liao TL, Chen DY, Lai CC. Metabolic disturbances in systemic lupus erythematosus evaluated with UPLC-MS\/MS. Clin Exp Rheumatol. 2024;42(1):15\u201323.","journal-title":"Clin Exp Rheumatol"},{"key":"3264_CR54","doi-asserted-by":"publisher","first-page":"110235","DOI":"10.1016\/j.clim.2024.110235","volume":"264","author":"J Liang","year":"2024","unstructured":"Liang J, Han Z, Feng J, et al. Targeted metabolomics combined with machine learning to identify and validate new biomarkers for early SLE diagnosis and disease activity. Clin Immunol. 2024;264:110235.","journal-title":"Clin Immunol"},{"issue":"1","key":"3264_CR55","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12964-025-02041-1","volume":"23","author":"J Chen","year":"2025","unstructured":"Chen J, Pan Q, Lu L, et al. Atg5 deficiency in basophils improves metabolism in lupus mice by regulating gut microbiota dysbiosis. Cell Commun Signal. 2025;23(1):40.","journal-title":"Cell Commun Signal"},{"key":"3264_CR56","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3389\/fimmu.2017.00023","volume":"8","author":"J Rodr\u00edguez-Carrio","year":"2017","unstructured":"Rodr\u00edguez-Carrio J, L\u00f3pez P, S\u00e1nchez B, et al. Intestinal dysbiosis is associated with altered short-chain fatty acids and serum-free fatty acids in systemic lupus erythematosus. Front Immunol. 2017;8:23.","journal-title":"Front Immunol"},{"key":"3264_CR57","doi-asserted-by":"publisher","first-page":"106997","DOI":"10.1016\/j.phrs.2023.106997","volume":"198","author":"J Mole\u00f3n","year":"2023","unstructured":"Mole\u00f3n J, Gonz\u00e1lez-Correa C, Mi\u00f1ano S, et al. Protective effect of microbiota-derived short chain fatty acids on vascular dysfunction in mice with systemic lupus erythematosus induced by toll like receptor 7 activation. Pharmacol Res. 2023;198:106997.","journal-title":"Pharmacol Res"},{"key":"3264_CR58","doi-asserted-by":"publisher","first-page":"1365554","DOI":"10.3389\/fimmu.2024.1365554","volume":"15","author":"X Wang","year":"2024","unstructured":"Wang X, Yuan W, Yang C, et al. Emerging role of gut microbiota in autoimmune diseases. Front Immunol. 2024;15:1365554.","journal-title":"Front Immunol"},{"issue":"8","key":"3264_CR59","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1016\/j.immuni.2024.05.025","volume":"57","author":"H Xu","year":"2024","unstructured":"Xu H, Zhang X, Wang X, et al. Cellular spermine targets JAK signaling to restrain cytokine-mediated autoimmunity. Immunity. 2024;57(8):1796-1811.e8.","journal-title":"Immunity"},{"issue":"20","key":"3264_CR60","doi-asserted-by":"publisher","first-page":"e2409837","DOI":"10.1002\/advs.202409837","volume":"12","author":"L Gao","year":"2025","unstructured":"Gao L, Zhang Y, Hu Z, et al. Microbiota-derived inosine suppresses systemic autoimmunity via restriction of B cell differentiation and migration. Adv Sci (Weinh). 2025;12(20):e2409837.","journal-title":"Adv Sci (Weinh)"},{"key":"3264_CR61","doi-asserted-by":"publisher","first-page":"1565416","DOI":"10.3389\/fcimb.2025.1565416","volume":"15","author":"X Chu","year":"2025","unstructured":"Chu X, Li S, Wang Y, et al. Alteration in gut microbiota accompanied by increased intestinal permeability and Tfh\/Tfr imbalance in patients with active SLE. Front Cell Infect Microbiol. 2025;15:1565416.","journal-title":"Front Cell Infect Microbiol"},{"issue":"3","key":"3264_CR62","first-page":"857","volume":"12","author":"Y Li","year":"2019","unstructured":"Li Y, Liang L, Deng X, Zhong L. Lipidomic and metabolomic profiling reveals novel candidate biomarkers in active systemic lupus erythematosus. Int J Clin Exp Pathol. 2019;12(3):857\u201366.","journal-title":"Int J Clin Exp Pathol"},{"issue":"2","key":"3264_CR63","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1159\/000495400","volume":"51","author":"C Tang","year":"2018","unstructured":"Tang C, Wang X, Xie Y, et al. 4-octyl itaconate activates Nrf2 signaling to inhibit pro-inflammatory cytokine production in peripheral blood mononuclear cells of Systemic Lupus Erythematosus patients. Cell Physiol Biochem. 2018;51(2):979\u201390.","journal-title":"Cell Physiol Biochem"},{"issue":"12","key":"3264_CR64","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1002\/art.42284","volume":"74","author":"LP Blanco","year":"2022","unstructured":"Blanco LP, Patino-Martinez E, Nakabo S, et al. Modulation of the itaconate pathway attenuates murine lupus. Arthritis Rheumatol. 2022;74(12):1971\u201383.","journal-title":"Arthritis Rheumatol"},{"key":"3264_CR65","doi-asserted-by":"publisher","first-page":"109939","DOI":"10.1016\/j.clim.2024.109939","volume":"261","author":"MM Furment","year":"2024","unstructured":"Furment MM, Perl A. Immunometabolism of systemic lupus erythematosus. Clin Immunol. 2024;261:109939.","journal-title":"Clin Immunol"},{"issue":"7","key":"3264_CR66","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1002\/art.42840","volume":"76","author":"W Li","year":"2024","unstructured":"Li W, Tang X, Zheng Y, et al. Phosphatidic acid promoting the generation of interleukin-17A producing double-negative T cells by enhancing mTORC1 signaling in lupus. Arthritis Rheumatol. 2024;76(7):1096\u2013108.","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"3264_CR67","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41584-019-0356-x","volume":"16","author":"A Sharabi","year":"2020","unstructured":"Sharabi A, Tsokos GC. T cell metabolism: new insights in systemic lupus erythematosus pathogenesis and therapy. Nat Rev Rheumatol. 2020;16(2):100\u201312.","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"3264_CR68","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.semarthrit.2019.09.022","volume":"50","author":"J He","year":"2020","unstructured":"He J, Ma J, Ren B, Liu A. Advances in systemic lupus erythematosus pathogenesis via mTOR signaling pathway. Semin Arthritis Rheum. 2020;50(2):314\u201320.","journal-title":"Semin Arthritis Rheum"},{"issue":"11","key":"3264_CR69","doi-asserted-by":"publisher","first-page":"103910","DOI":"10.1016\/j.autrev.2025.103910","volume":"24","author":"D Michailidou","year":"2025","unstructured":"Michailidou D, Gartshteyn Y, Askanase AD, Perl A. The role of mTOR signaling pathway in systemic lupus erythematosus and systemic vasculitis. Autoimmun Rev. 2025;24(11):103910.","journal-title":"Autoimmun Rev"},{"key":"3264_CR70","doi-asserted-by":"publisher","first-page":"1155421","DOI":"10.3389\/fimmu.2023.1155421","volume":"14","author":"S Iwata","year":"2023","unstructured":"Iwata S, Hajime Sumikawa M, Tanaka Y. B cell activation via immunometabolism in systemic lupus erythematosus. Front Immunol. 2023;14:1155421.","journal-title":"Front Immunol"},{"issue":"9","key":"3264_CR71","doi-asserted-by":"publisher","first-page":"3830","DOI":"10.1093\/rheumatology\/keac037","volume":"61","author":"Z Mao","year":"2022","unstructured":"Mao Z, Tan Y, Tao J, et al. Renal mTORC1 activation is associated with disease activity and prognosis in lupus nephritis. Rheumatology (Oxford). 2022;61(9):3830\u201340.","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"3264_CR72","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1093\/abbs\/gmy088","volume":"50","author":"X Li","year":"2018","unstructured":"Li X, Zhang X, Pan Y, et al. mTOR regulates NLRP3 inflammasome activation via reactive oxygen species in murine lupus. Acta Biochim Biophys Sin. 2018;50(9):888\u201396.","journal-title":"Acta Biochim Biophys Sin"},{"issue":"6","key":"3264_CR73","doi-asserted-by":"publisher","first-page":"531","DOI":"10.7555\/JBR.38.20240009","volume":"38","author":"V Chasov","year":"2024","unstructured":"Chasov V, Zmievskaya E, Ganeeva I, et al. Systemic lupus erythematosus therapeutic strategy: from immunotherapy to gut microbiota modulation. J Biomed Res. 2024;38(6):531\u201346.","journal-title":"J Biomed Res"},{"issue":"7\u20138","key":"3264_CR74","doi-asserted-by":"publisher","first-page":"103541","DOI":"10.1016\/j.autrev.2024.103541","volume":"23","author":"I Seida","year":"2024","unstructured":"Seida I, Al Shawaf M, Mahroum N. Fecal microbiota transplantation in autoimmune diseases - an extensive paper on a pathogenetic therapy. Autoimmun Rev. 2024;23(7\u20138):103541.","journal-title":"Autoimmun Rev"},{"key":"3264_CR75","doi-asserted-by":"publisher","first-page":"103047","DOI":"10.1016\/j.jaut.2023.103047","volume":"141","author":"B Zhang","year":"2023","unstructured":"Zhang B, Zhou W, Liu Q, et al. Effects of fecal microbiota transplant on DNA methylation in patients with systemic lupus erythematosus. J Autoimmun. 2023;141:103047.","journal-title":"J Autoimmun"},{"key":"3264_CR76","doi-asserted-by":"publisher","first-page":"102844","DOI":"10.1016\/j.jaut.2022.102844","volume":"130","author":"C Huang","year":"2022","unstructured":"Huang C, Yi P, Zhu M, et al. Safety and efficacy of fecal microbiota transplantation for treatment of systemic lupus erythematosus: an EXPLORER trial. J Autoimmun. 2022;130:102844.","journal-title":"J Autoimmun"},{"key":"3264_CR77","doi-asserted-by":"publisher","first-page":"102989","DOI":"10.1016\/j.jaut.2022.102989","volume":"135","author":"M Zheng","year":"2023","unstructured":"Zheng M, Zhou W, Huang C, et al. A single-cell map of peripheral alterations after FMT treatment in patients with systemic lupus erythematosus. J Autoimmun. 2023;135:102989.","journal-title":"J Autoimmun"},{"issue":"1","key":"3264_CR78","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/jleuko\/qiac002","volume":"113","author":"JW Harder","year":"2023","unstructured":"Harder JW, Ma J, Alard P, et al. Male microbiota-associated metabolite restores macrophage efferocytosis in female lupus-prone mice via activation of PPAR\u03b3\/LXR signaling pathways. J Leukoc Biol. 2023;113(1):41\u201357.","journal-title":"J Leukoc Biol"},{"issue":"1","key":"3264_CR79","doi-asserted-by":"publisher","first-page":"26371","DOI":"10.1038\/s41598-024-77672-4","volume":"14","author":"P Chatthanathon","year":"2024","unstructured":"Chatthanathon P, Leelahavanichkul A, Cheibchalard T, Wilantho A, Hirankarn N, Somboonna N. Comparative time-series analyses of gut microbiome profiles in genetically and chemically induced lupus-prone mice and the impacts of fecal transplantation [published correction appears in Sci Rep. 2024 Nov 26;14(1):29391.]. Sci Rep. 2024;14(1):26371.","journal-title":"Sci Rep"},{"issue":"1","key":"3264_CR80","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s12602-024-10297-1","volume":"17","author":"RC Goh","year":"2025","unstructured":"Goh RC, Maharajan MK, Gopinath D, Fang CM. The therapeutic effects of probiotic on systemic lupus erythematosus in lupus mice models: a systematic review. Probiotics Antimicrob Proteins. 2025;17(1):35\u201350.","journal-title":"Probiotics Antimicrob Proteins"},{"issue":"2","key":"3264_CR81","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1039\/D4FO03966A","volume":"16","author":"W Liao","year":"2025","unstructured":"Liao W, Zhang X, Jia C, et al. Lactobacillus rhamnosus LC-STH-13 ameliorates the progression of SLE in MRL\/lpr mice by inhibiting the TLR9\/NF-\u03baB signaling pathway. Food Funct. 2025;16(2):475\u201386.","journal-title":"Food Funct"},{"issue":"1","key":"3264_CR82","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s12916-024-03303-4","volume":"22","author":"L Zeng","year":"2024","unstructured":"Zeng L, Yang K, He Q, et al. Efficacy and safety of gut microbiota-based therapies in autoimmune and rheumatic diseases: a systematic review and meta-analysis of 80 randomized controlled trials. BMC Med. 2024;22(1):110.","journal-title":"BMC Med"},{"key":"3264_CR83","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaf271","author":"L Wu","year":"2025","unstructured":"Wu L, Guan Z, Zhang X, et al. Bifidobacterium ameliorates lupus nephritis and modulates aberrant differentiation of lymphocyte subsets. Rheumatology (Oxford). 2025. https:\/\/doi.org\/10.1093\/rheumatology\/keaf271.","journal-title":"Rheumatology (Oxford)"},{"key":"3264_CR84","doi-asserted-by":"publisher","first-page":"923754","DOI":"10.3389\/fimmu.2022.923754","volume":"13","author":"X Cabana-Puig","year":"2022","unstructured":"Cabana-Puig X, Mu Q, Lu R, et al. Lactobacillus spp. act in synergy to attenuate splenomegaly and lymphadenopathy in lupus-prone MRL\/lpr mice. Front Immunol. 2022;13:923754.","journal-title":"Front Immunol"},{"issue":"5","key":"3264_CR85","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1007\/s00011-023-01731-1","volume":"72","author":"X Cabana-Puig","year":"2023","unstructured":"Cabana-Puig X, Lu R, Geng S, et al. CX3CR1 modulates SLE-associated glomerulonephritis and cardiovascular disease in MRL\/lpr mice. Inflamm Res. 2023;72(5):1083\u201397.","journal-title":"Inflamm Res"},{"issue":"4","key":"3264_CR86","doi-asserted-by":"publisher","first-page":"e0007023","DOI":"10.1128\/msphere.00070-23","volume":"8","author":"M Guo","year":"2023","unstructured":"Guo M, Lu M, Chen K, et al. Akkermansia muciniphila\u00a0and\u00a0Lactobacillus plantarum\u00a0ameliorate systemic lupus erythematosus by possibly regulating immune response and remodeling gut microbiota. mSphere. 2023;8(4):e0007023.","journal-title":"mSphere"},{"key":"3264_CR87","doi-asserted-by":"publisher","first-page":"696074","DOI":"10.3389\/fimmu.2021.696074","volume":"12","author":"DS Kim","year":"2021","unstructured":"Kim DS, Park Y, Choi JW, Park SH, Cho ML, Kwok SK. Lactobacillus acidophilus supplementation exerts a synergistic effect on tacrolimus efficacy by modulating Th17\/Treg balance in lupus-prone mice via the SIGNR3 pathway. Front Immunol. 2021;12:696074.","journal-title":"Front Immunol"},{"issue":"8","key":"3264_CR88","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.3390\/nu13082669","volume":"13","author":"N de la Visitaci\u00f3n","year":"2021","unstructured":"de la Visitaci\u00f3n N, Robles-Vera I, Mole\u00f3n-Moya J, et al. Probiotics prevent hypertension in a murine model of Systemic Lupus Erythematosus induced by Toll-like receptor 7 activation. Nutrients. 2021;13(8):2669.","journal-title":"Nutrients"},{"issue":"9","key":"3264_CR89","doi-asserted-by":"publisher","first-page":"10005","DOI":"10.1096\/fj.201900545RR","volume":"33","author":"M Toral","year":"2019","unstructured":"Toral M, Robles-Vera I, Romero M, et al. Lactobacillus fermentum CECT5716: a novel alternative for the prevention of vascular disorders in a mouse model of systemic lupus erythematosus. FASEB J. 2019;33(9):10005\u201318.","journal-title":"FASEB J"},{"issue":"5","key":"3264_CR90","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1177\/09612033231161961","volume":"32","author":"N Ramessar","year":"2023","unstructured":"Ramessar N, Borad A, Schlesinger N. The impact of curcumin supplementation on systemic lupus erythematosus and lupus nephritis: a systematic review. Lupus. 2023;32(5):644\u201357.","journal-title":"Lupus"},{"issue":"4","key":"3264_CR91","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3892\/mmr.2024.13306","volume":"30","author":"R Huo","year":"2024","unstructured":"Huo R, Yang Y, Huo X, Meng D, Huang R, Yang Y, et al. Potential of resveratrol in the treatment of systemic lupus erythematosus (Review). Mol Med Rep. 2024;30(4):182.","journal-title":"Mol Med Rep"},{"key":"3264_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.bj.2024.100754","author":"SH Chang","year":"2024","unstructured":"Chang SH, Ko YF, Liau JC, et al. Hirsutella sinensis polysaccharides and Parabacteroides goldsteinii reduce lupus severity in imiquimod-treated mice. Biomed J. 2024. https:\/\/doi.org\/10.1016\/j.bj.2024.100754.","journal-title":"Biomed J"},{"issue":"12","key":"3264_CR93","doi-asserted-by":"publisher","first-page":"9835","DOI":"10.1111\/1750-3841.17460","volume":"89","author":"Z Mirfeizi","year":"2024","unstructured":"Mirfeizi Z, Mahmoudi M, Jokar MH, et al. Impact of synbiotics on disease activity in systemic lupus erythematosus: results from a randomized clinical trial. J Food Sci. 2024;89(12):9835\u201345.","journal-title":"J Food Sci"},{"issue":"21","key":"3264_CR94","doi-asserted-by":"publisher","first-page":"3419","DOI":"10.3390\/cells11213419","volume":"11","author":"A Widhani","year":"2022","unstructured":"Widhani A, Djauzi S, Suyatna FD, Dewi BE. Changes in gut microbiota and systemic inflammation after synbiotic supplementation in patients with Systemic lupus erythematosus: a randomized, double-blind, placebo-controlled trial. Cells. 2022;11(21):3419.","journal-title":"Cells"},{"key":"3264_CR95","doi-asserted-by":"publisher","first-page":"1295378","DOI":"10.3389\/fmicb.2024.1295378","volume":"15","author":"Q Zhu","year":"2024","unstructured":"Zhu Q, Cui J, Liu S, Wei S, Wu Q, You Y. Synbiotic regulates gut microbiota in patients with lupus nephritis: an analysis using metagenomic and metabolome sequencing. Front Microbiol. 2024;15:1295378.","journal-title":"Front Microbiol"},{"issue":"6","key":"3264_CR96","first-page":"22","volume":"21","author":"J Kielmann","year":"2022","unstructured":"Kielmann J, Pucci L, Xydis A. Personalized nutrition and lifestyle interventions in systemic lupus erythematosus: a case report. Integr Med (Encinitas). 2022;21(6):22\u20137.","journal-title":"Integr Med (Encinitas)"},{"issue":"2","key":"3264_CR97","doi-asserted-by":"publisher","first-page":"2247053","DOI":"10.1080\/19490976.2023.2247053","volume":"15","author":"J Mole\u00f3n","year":"2023","unstructured":"Mole\u00f3n J, Gonz\u00e1lez-Correa C, Robles-Vera I, et al. Targeting the gut microbiota with dietary fibers: a novel approach to prevent the development cardiovascular complications linked to systemic lupus erythematosus in a preclinical study. Gut Microbes. 2023;15(2):2247053.","journal-title":"Gut Microbes"},{"issue":"1","key":"3264_CR98","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.chom.2018.11.009","volume":"25","author":"DF Zegarra-Ruiz","year":"2019","unstructured":"Zegarra-Ruiz DF, El Beidaq A, I\u00f1iguez AJ, et al. A diet-sensitive commensal Lactobacillus strain mediates TLR7-dependent systemic autoimmunity. Cell Host Microbe. 2019;25(1):113-127.e6.","journal-title":"Cell Host Microbe"},{"issue":"4","key":"3264_CR99","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41423-023-00987-1","volume":"20","author":"CH Kim","year":"2023","unstructured":"Kim CH. Complex regulatory effects of gut microbial short-chain fatty acids on immune tolerance and autoimmunity. Cell Mol Immunol. 2023;20(4):341\u201350.","journal-title":"Cell Mol Immunol"},{"issue":"12","key":"3264_CR100","doi-asserted-by":"publisher","first-page":"102688","DOI":"10.1016\/j.autrev.2020.102688","volume":"19","author":"A Duarte-Garc\u00eda","year":"2020","unstructured":"Duarte-Garc\u00eda A, Myasoedova E, Karmacharya P, et al. Effect of omega-3 fatty acids on systemic lupus erythematosus disease activity: a systematic review and meta-analysis. Autoimmun Rev. 2020;19(12):102688.","journal-title":"Autoimmun Rev"},{"issue":"12","key":"3264_CR101","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.3390\/nu16121974","volume":"16","author":"B Wang","year":"2024","unstructured":"Wang B, Wang H, Huang J, Zhao T. Association between unsaturated fatty acid-type diet and systemic lupus erythematosus: a systematic review with meta-analyses. Nutrients. 2024;16(12):1974.","journal-title":"Nutrients"},{"issue":"2","key":"3264_CR102","doi-asserted-by":"publisher","first-page":"504","DOI":"10.3390\/nu13020504","volume":"13","author":"M Kono","year":"2021","unstructured":"Kono M, Nagafuchi Y, Shoda H, Fujio K. The impact of obesity and a high-fat diet on clinical and immunological features in systemic lupus erythematosus. Nutrients. 2021;13(2):504.","journal-title":"Nutrients"},{"issue":"1","key":"3264_CR103","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1093\/rheumatology\/keaa210","volume":"60","author":"G Pocovi-Gerardino","year":"2021","unstructured":"Pocovi-Gerardino G, Correa-Rodr\u00edguez M, Callejas-Rubio JL, et al. Beneficial effect of Mediterranean diet on disease activity and cardiovascular risk in systemic lupus erythematosus patients: a cross-sectional study. Rheumatology (Oxford). 2021;60(1):160\u20139.","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"3264_CR104","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.chom.2019.01.017","volume":"25","author":"AN Shkoporov","year":"2019","unstructured":"Shkoporov AN, Hill C. Bacteriophages of the Human Gut: The \u201cKnown Unknown\u201d of the Microbiome. Cell Host Microbe. 2019;25(2):195\u2013209.","journal-title":"Cell Host Microbe"},{"issue":"2","key":"3264_CR105","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1136\/annrheumdis-2021-221267","volume":"81","author":"Y Tomofuji","year":"2022","unstructured":"Tomofuji Y, Kishikawa T, Maeda Y, et al. Whole gut virome analysis of 476 Japanese revealed a link between phage and autoimmune disease. Ann Rheum Dis. 2022;81(2):278\u201388.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"3264_CR106","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13075-023-03022-w","volume":"25","author":"X Yi","year":"2023","unstructured":"Yi X, Huang C, Huang C, Zhao M, Lu Q. Fecal microbiota from MRL\/lpr mice exacerbates pristane-induced lupus. Arthritis Res Ther. 2023;25(1):42\u20139.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"3264_CR107","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12866-022-02533-x","volume":"22","author":"XB Li","year":"2022","unstructured":"Li XB, Chu XJ, Cao NW, et al. Proton pump inhibitors induce changes in the gut microbiome composition of systemic lupus erythematosus patients. BMC Microbiol. 2022;22(1):117.","journal-title":"BMC Microbiol"},{"issue":"9","key":"3264_CR108","doi-asserted-by":"publisher","first-page":"103607","DOI":"10.1016\/j.autrev.2024.103607","volume":"23","author":"MG Danieli","year":"2024","unstructured":"Danieli MG, Antonelli E, Longhi E, Gangemi S, Allegra A. The role of microbiota and oxidative stress axis and the impact of intravenous immunoglobulin in systemic lupus erythematosus. Autoimmun Rev. 2024;23(9):103607.","journal-title":"Autoimmun Rev"},{"issue":"1","key":"3264_CR109","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s11658-025-00716-8","volume":"30","author":"Q Pan","year":"2025","unstructured":"Pan Q, Guo F, Chen J, et al. Exploring the role of gut microbiota modulation in the long-term therapeutic benefits of early MSC transplantation in MRL\/lpr mice. Cell Mol Biol Lett. 2025;30(1):49.","journal-title":"Cell Mol Biol Lett"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03264-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-03264-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03264-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T16:05:23Z","timestamp":1760457923000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-03264-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,14]]},"references-count":109,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3264"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-03264-1","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,14]]},"assertion":[{"value":"15 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"971"}}